Selank vs phenibut: how these two really compare

Last updated 2026-07-26

what are selank and phenibut, actually

Selank is a synthetic heptapeptide, a lab-made analog of the immune peptide tuftsin, developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1990s ^[1]. It's registered in Russia as a prescription anxiolytic nasal drop, sold there under the name Selank. It's not approved by the FDA for any use in the United States and it isn't a dietary supplement either; in the US it exists mostly as a research chemical people buy for self-directed use. Phenibut is a completely different class of molecule. Chemically it's a phenyl derivative of GABA (beta-phenyl-gamma-aminobutyric acid), originally developed in the Soviet Union in the 1960s and still used in Russia as a prescription anxiolytic and sometimes issued to cosmonauts for stress ^[2]. It crosses the blood-brain barrier and acts directly on GABA-B receptors, plus weaker GABA-A activity at higher doses, which is exactly why it feels like a sedative and why it carries dependence risk. The two get lumped together constantly because they share a Russian pharmacology pedigree and both get marketed online as anti-anxiety compounds. But their mechanisms, safety profiles, and abuse potential are not remotely similar. That distinction matters more than almost anything else in this comparison.

how do selank and phenibut work differently in the brain

Phenibut's action is straightforward pharmacology: it binds GABA-B receptors (the same receptor family targeted by baclofen) and produces a calming, sometimes disinhibiting effect similar in feel to a mild benzodiazepine or alcohol. That's a big part of why people like it, and also why the brain adapts to it fast, downregulating receptor sensitivity with repeated use. Selank doesn't work through GABA receptors at all. Russian pharmacology work describes it as modulating the balance of brain-derived neurotrophic factor (BDNF) expression and influencing serotonin and dopamine turnover, alongside effects on the enzyme that breaks down enkephalins (peptidase inhibition) ^[1]. It's proposed to be a nootropic-anxiolytic hybrid rather than a sedative. Users typically describe it as taking the edge off anxiety without the drowsiness or intoxication you get from phenibut or a benzo. The practical difference: phenibut's calming effect is sedation you can feel building up to actual impairment at high doses. Selank's reported effect is more like anxiety just being quieter in the background, with no reported intoxication threshold in the literature. This is exactly the kind of mechanistic difference readers confuse with selank vs semax, another sibling peptide, though semax targets nootropic and neuroprotective effects more than anxiolysis specifically.

which one has better clinical evidence

Neither has passed through a Western regulatory trial process, and that has to be said plainly every time. Selank's evidence base is a set of Russian-language clinical and preclinical studies, mostly small, done in the 1990s-2010s, published in Russian pharmacology journals with limited or no English-language replication. A frequently cited human study found selank comparable to a benzodiazepine (medazepam) for generalized anxiety disorder symptoms over a short treatment course, but it's not a large randomized trial by FDA standards and hasn't been independently repeated outside Russia ^[3]. Phenibut actually has somewhat more accessible pharmacological characterization in Western literature, partly because it shows up in emergency medicine and toxicology journals covering withdrawal and overdose cases, not because anyone ran efficacy trials on it. A review in the Journal of Medical Toxicology summarized dozens of case reports of phenibut withdrawal and dependence, describing symptoms including anxiety, insomnia, tremor, and in severe cases hallucinations and delirium requiring hospitalization ^[4]. So the evidence asymmetry is almost backward from what you'd expect: selank has thin efficacy data but almost no documented harm data, while phenibut has thin efficacy data and a real, growing body of harm data. Neither situation should be mistaken for FDA-level proof of anything. If you want to see selank's evidence laid out in full, the selank overview covers the primary studies in more depth.

does phenibut cause dependence and withdrawal (and does selank)

Yes, phenibut dependence and withdrawal are well documented, not a fringe theory. Case series in toxicology and psychiatry journals describe a withdrawal syndrome that resembles benzodiazepine or alcohol withdrawal: rebound anxiety, insomnia, tachycardia, tremor, and in more severe cases seizures and psychosis, typically emerging within 24 to 48 hours of stopping regular use ^{[4] [5]}. Tolerance builds with repeated daily dosing, which pushes some users toward escalating doses, a classic dependence spiral. Selank has no comparable documented withdrawal syndrome in its clinical literature. That's a genuinely important difference, but it comes with a caveat: the absence of reported withdrawal is partly because the studies are small, short-duration, and conducted under controlled Russian clinical settings, not because thousands of long-term recreational users have been tracked. Nobody has good long-term dependence data on selank in the way we now have for phenibut, because phenibut's harms surfaced through real-world misuse at scale (much of it via US nootropic forums and retail sales) while selank never reached that level of casual daily use in the West. If you're deciding between the two specifically to avoid a withdrawal trap, phenibut is the one with the documented trap. That's not a close call.

how do the typical doses and routes compare

which is safer, selank or phenibut

On the current evidence, selank looks meaningfully safer for regular or repeated use. It has no documented withdrawal syndrome, no established lethal dose in humans reported in the literature, and animal toxicology work suggests a wide safety margin, though again, this is mostly Russian preclinical data, not FDA-reviewed safety trials ^[1]. Phenibut has real, documented acute and chronic risks. Overdose cases show sedation progressing to respiratory depression, especially when phenibut is combined with alcohol or other GABAergic drugs (benzodiazepines, opioids), a combination flagged repeatedly in poison control and toxicology reports ^{[4] [5]}. Chronic daily users report escalating doses to fight the growing tolerance, precisely the pattern that leads to the withdrawal cases described above. That doesn't make selank risk-free. Anyone considering it should read selank side effects before starting, because even a comparatively benign-looking peptide can cause headache, nasal irritation from intranasal dosing, or mild sedation in some users, and because 'not documented' isn't the same as 'proven safe long-term.' The honest read: selank's downside risk looks lower, but the confidence interval on that claim is wide because the total user population studied is small.

can you take selank and phenibut together

There's no clinical study on combining selank and phenibut, so anything said here is mechanistic reasoning, not trial data. Because they work through different systems (selank isn't GABAergic, phenibut is), there's no obvious pharmacodynamic clash the way there would be combining phenibut with a benzodiazepine or alcohol. That said, combining any two centrally-acting compounds without data on the interaction is a decision you're making on your own, not one backed by a safety study. If someone is using phenibut for its GABAergic sedative effect and adding selank hoping for extra anxiolysis, they're stacking an established-risk compound with an under-studied one and hoping the sum of unknowns behaves predictably. It might; nobody has tested it. The more common failure mode people report isn't a scary interaction, it's disappointment: phenibut's sedation masks whatever selank is or isn't doing, so you can't tell which drug is responsible for any given effect.

is selank or phenibut better for anxiety

For generalized anxiety symptoms specifically, the Russian clinical literature on selank found effects comparable to a low-dose benzodiazepine over a short treatment window, without the sedation ^[3]. That's a meaningful finding if it replicates, but it comes from a study design and publication environment that hasn't been vetted by Western peer review standards, and it hasn't been repeated independently outside Russia. Phenibut does reduce anxiety acutely, that's not really in dispute pharmacologically since GABA-B agonism is anxiolytic by mechanism. The problem is durability: anxiety relief from phenibut degrades with tolerance over days to weeks of regular use, and stopping it often produces rebound anxiety worse than baseline, which is the exact opposite of what someone using it for anxiety wants long-term ^[4]. So for a one-off, occasional-use anxiolytic effect, phenibut probably feels stronger in the moment because of its direct GABA action. For anything approaching daily or routine anxiety management, selank's profile, thin as the evidence is, looks like the more sustainable choice specifically because it doesn't carry a known tolerance curve.

is selank or phenibut better for focus and cognition

This isn't really a fair fight. Phenibut is a sedative-anxiolytic; it's not marketed or studied as a cognitive enhancer, and users who report improved focus on it are usually just experiencing anxiety reduction letting them concentrate, not a direct nootropic effect. Selank has some Russian preclinical work suggesting effects on BDNF expression and memory consolidation in animal models, and it gets used off-label by some as a mild nootropic alongside its anxiolytic reputation, sometimes stacked with its sibling peptide semax, which has a stronger nootropic and neuroprotective evidence base. If cognitive enhancement is actually the goal rather than anxiety, semax vs selank is the more relevant comparison to read, since semax's literature leans harder into cognition and neuroprotection while selank leans into anxiolysis.

how do the legal status and sourcing compare

Neither selank nor phenibut is FDA-approved for any indication in the United States. Selank is sold domestically as a research chemical, typically as an injectable solution or nasal spray from compounding-adjacent suppliers, with quality and purity varying a lot between vendors since there's no FDA oversight of these products ^[6]. Phenibut's legal status is messier and state-dependent. It's not federally scheduled in the US, but some states have moved to restrict or ban it; Kentucky and Georgia are among states that have taken regulatory action against phenibut sales, and it's a prescription or controlled substance in several other countries ^[7]. It got FDA warning letters over marketing claims when sold as a dietary supplement, since the FDA has stated phenibut doesn't meet the definition of a legal dietary supplement ingredient . Because purity and actual dosing accuracy vary so much with unregulated peptides, sourcing selank through a provider-reviewed path matters. Selank Co reviews suppliers and points buyers toward pharmacies that actually fulfill orders rather than anonymous international vendors, which is a meaningfully different risk profile than ordering a bag of white powder off a marketplace site.

how do side effects compare day to day

Phenibut's common side effects at typical doses include sedation, dizziness, nausea, and headache, with the sedation becoming pronounced and dangerous at higher doses or combined with alcohol ^{[4] [5]}. Next-day grogginess is a common complaint given phenibut's longer duration of action and the buildup that happens with repeated daily dosing. Selank's reported side effects in the Russian clinical literature are comparatively mild and infrequent: transient nasal irritation with intranasal dosing, occasional mild headache, rare reports of drowsiness ^{[1] [1]}. There's no equivalent of phenibut's next-day fog described in the literature, though again, the total number of studied users is small compared to phenibut's real-world footprint. The standout difference isn't which side effect list is longer, it's what happens after you stop. Stopping phenibut after regular use can trigger a genuine withdrawal syndrome. Stopping selank, based on available data, doesn't appear to. That asymmetry should weigh heavily on anyone choosing between them for regular, ongoing use.

Frequently asked questions

Is selank the same as phenibut?

No. Selank is a synthetic peptide that doesn't act on GABA receptors; phenibut is a small-molecule GABA-B agonist chemically related to GABA itself. They're both Russian-developed anxiolytics but work through completely different mechanisms, and only phenibut has documented tolerance and withdrawal risk.

Which is stronger, selank or phenibut?

Phenibut produces a more noticeable acute sedative or 'buzzed' feeling because it directly activates GABA-B receptors. Selank's reported effect is subtler, described as reduced anxiety without sedation. 'Stronger' depends on what you're measuring; phenibut wins on felt intensity, selank arguably wins on sustainability.

Can selank help with phenibut withdrawal?

There's no clinical study testing selank for phenibut withdrawal, so this isn't an evidence-backed use. Phenibut withdrawal can involve seizures and psychosis in severe cases and typically needs medical management (sometimes a GABA-B agonist taper like baclofen), not an unstudied peptide.

Is phenibut more dangerous than selank?

Based on published case reports, yes. Phenibut has documented withdrawal syndromes, overdose cases, and dangerous interactions with alcohol and other sedatives. Selank has no comparable documented harm profile, though its total studied user base is much smaller, which limits how confident anyone can be.

Does selank cause withdrawal like phenibut does?

No withdrawal syndrome for selank has been described in the clinical literature, unlike phenibut's well-documented rebound anxiety, insomnia, and in severe cases seizures. That said, selank's studies are small and short-term, so long-term dependence patterns simply haven't been tested at scale.

Is selank legal in the United States?

Selank isn't FDA-approved for any use and isn't sold as a dietary supplement; it exists in the US as an unscheduled research chemical. It's approved as a prescription anxiolytic in Russia, but that's a Russian regulatory approval, not an FDA one.

Is phenibut legal in the United States?

Phenibut isn't federally scheduled, but it's not FDA-approved either, and the FDA has said it doesn't qualify as a legal dietary supplement ingredient. Some states have taken separate action against its sale, so legal status varies by state.

Can you take selank and phenibut on the same day?

No study has tested this combination. Because selank isn't GABAergic, there's no obvious direct pharmacological clash with phenibut, but that's mechanistic reasoning, not safety data. Combining any two centrally-acting compounds without interaction data is done at your own risk.

Which is better for social anxiety, selank or phenibut?

Phenibut's GABA-B activity gives a more immediate anti-anxiety and mild disinhibiting effect, which is why it got popular for social anxiety, but tolerance and rebound anxiety make it a poor long-term fit. Selank's evidence, while thinner, suggests steadier anxiolysis without that tolerance pattern.

Does selank have the same abuse potential as phenibut?

No documented recreational abuse pattern exists for selank in the clinical literature. Phenibut has a well-established pattern of dose escalation and dependence documented in toxicology journals, largely because its GABAergic action produces a rewarding, alcohol-like effect that selank's mechanism doesn't replicate.

How do selank and semax relate to phenibut?

Selank and semax are sibling peptides from the same Russian research lineage, both unrelated to phenibut's GABAergic mechanism. Semax leans toward cognitive and neuroprotective effects while selank leans toward anxiolysis; neither carries phenibut's documented dependence risk. See selank vs semax for that comparison specifically.

What's the evidence quality difference between selank and phenibut studies?

Both have thin efficacy evidence by FDA standards: small, mostly Russian-language trials for selank, and essentially no controlled efficacy trials for phenibut. Phenibut's Western literature is dominated by toxicology case reports of harm, while selank's Western presence is nearly nonexistent outside translated Russian sources.

Sources

1. Institute of Molecular Genetics, Russian Academy of Sciences (peptide research history): Selank is a synthetic heptapeptide analog of tuftsin developed by Russian researchers, dosed intranasally in the low microgram range
2. PubMed - Phenibut pharmacology and history: Phenibut is a GABA-B receptor agonist developed in the Soviet Union and used clinically in Russia
3. PubMed - Selank clinical anxiolytic study: A Russian clinical study found selank comparable to a benzodiazepine for generalized anxiety symptoms over a short course
4. Journal of Medical Toxicology - Phenibut withdrawal case reports: Phenibut withdrawal presents with anxiety, insomnia, tremor, and in severe cases hallucinations and delirium requiring hospitalization
5. PubMed - Phenibut toxicity and overdose: Phenibut overdose and combination with alcohol or other sedatives is associated with respiratory depression and hospitalization
6. FDA - Compounding and unapproved drug oversight: Products like selank sold outside FDA-approved channels are not subject to standard FDA quality oversight
7. Georgia General Assembly - Controlled substances scheduling actions: Some US states have taken separate legislative action to restrict phenibut sales